Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.

Medicine - 3 May 2024

Ding Wenjing, Chen Liangliang, Xia Jianguo, Pei Bei, Song Biao, Li Xuejun

Abstract excerpt

Accumulating evidences have indicated that lipid-lowering drugs have effect for the treatment of cancers. However, causal associations between lipid-lowering drugs and the risk of cancers are still unclear. In our study, we utilized single nucleotide polymorphisms of proprotein convertase subtilis kexin 9 (PCSK9) inhibitors and 3-hydroxy-3-methylglutaryl-assisted enzyme A reductase (HMGCR) inhibitors and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors
Share to Hydroxymethylglutaryl CoA Reductases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypolipidemic Agents

Share to Mendelian Randomization Analysis

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Proprotein Convertase 9

Source

Open in PubMed Open full text

Identifiers

PMID: 38701318
DOI: 10.1097/MD.0000000000038010
PMCID: PMC11062692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.PMID 38701318Read ↗

Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.Semantic proximity Read ↗

The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug TargetingSemantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study.Semantic proximity Read ↗

Lipids, lipid-modifying drug Target genes and Bladder cancer: a Mendelian randomization studySemantic proximity Read ↗

Potential drug targets for tumors identified through Mendelian randomization analysis.Semantic proximity Read ↗

Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization studySemantic proximity Read ↗

Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization StudySemantic proximity Read ↗

Causal relationship between drug target genes of LDL-cholesterol and coronary artery disease: Drug Target Mendelian Randomization StudySemantic proximity Read ↗

Causal relationship between PCSK9 inhibitor and common neurodegenerative diseases: A drug target Mendelian randomization study.Semantic proximity Read ↗

Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.